Perioperative Surgical Recommendations in Patients with Lupus

Main Article Content

Donovan Diego Ruiz Baltazar
Mariana García Morales
Julie Rosario Guadalupe Barruquin
Jocelyn Anaid Landeros Fraire
Francisco Javier Delgado Dávalos
Sergio González Ramírez
José Raúl Rodríguez Amparán
Ernesto Fernando Montelongo Sedano
José Manuel Villafuerte Hernández
Ana Denisse Aboytes Bucio
Carlos Mario González García
Doryan Monroy Cordoba

Abstract

Systemic lupus erythematosus (SLE) is a long-lasting autoimmune condition that affects the connective tissues and has a varied and diverse range of symptoms. The severity of the disease varies greatly, with the majority experiencing less severe versions. However, it may be life-threatening depending on the extent of organ involvement. The ailment was identified as early as the Middle Ages, with the 12th-century physician Rogerius being the first to use the name lupus to describe the characteristic malar rash. In 1872, Moric Kaposi was the first to acknowledge the systemic aspect of the disease. During the perioperative period, systemic lupus erythematosus (SLE) may provide significant difficulties for the anesthesiologist due to the presence of accumulated organ damage, coagulation abnormalities, and intricate care protocols. This article focuses on the signs and therapies of adult systemic lupus erythematosus (SLE) that are relevant to anesthesiologists. It also discusses the perioperative care of these patients, who present unique challenges due to the complexity of their condition.

Article Details

How to Cite
Donovan Diego Ruiz Baltazar, Mariana García Morales, Julie Rosario Guadalupe Barruquin, Jocelyn Anaid Landeros Fraire, Francisco Javier Delgado Dávalos, Sergio González Ramírez, José Raúl Rodríguez Amparán, Ernesto Fernando Montelongo Sedano, José Manuel Villafuerte Hernández, Ana Denisse Aboytes Bucio, Carlos Mario González García, & Doryan Monroy Cordoba. (2024). Perioperative Surgical Recommendations in Patients with Lupus. International Journal of Medical Science and Clinical Research Studies, 4(08), 1555–1559. https://doi.org/10.47191/ijmscrs/v4-i08-24
Section
Articles

References

I. Boyce, M., & Massicotte, A. (2020). Practical guidance in perioperative management of immunosuppressive therapy for rheumatology patients undergoing elective surgery. The Canadian Journal of Hospital Pharmacy, 73(3), 218.

II. Zisa, D., & Goodman, S. M. (2021). Perioperative management of rheumatic disease and therapies. Medical Clinics, 105(2), 273-284.

III. Albrecht, K., Poddubnyy, D., Leipe, J., Sewerin, P., Iking-Konert, C., Scholz, R., & Krüger, K. (2023). Perioperative management of patients with inflammatory rheumatic diseases: Updated recommendations of the German Society for Rheumatology. Zeitschrift für Rheumatologie, 82(Suppl 1), 1-11.

IV. Nasution, H. N., & Rahmawati, L. D. (2021). Perioperative Management of Systemic Lupus Erythematosus Patient with Perianal Abscess Complication due to Trauma. Buletin Farmatera, 6(3), 205-213.

V. Vasavada, K., Jazrawi, L. M., & Samuels, J. (2021). Perioperative Management of Immunosuppressive Medications in Rheumatic Disease Patients Undergoing Arthroscopy. Current Reviews in Musculoskeletal Medicine, 1-8.

VI. Mamaril-Davis, J. C., Aguilar-Salinas, P., Avila, M. J., Villatoro-Villar, M., & Dumont, T. M. (2022). Perioperative management of disease-modifying antirheumatic drugs for patients undergoing elective spine surgery: a systematic review. European Spine Journal, 31(4), 815-829.

VII. Yamamoto, T., Matsushita, S., Endo, D., Shimada, A., Dohi, S., Kajimoto, K., ... & Amano, A. (2023). Management of cardiovascular surgery in patients with systemic lupus erythematosus including thromboembolism and multiple organ failure prevention: A retrospective observational study. Medicine, 102(7), e32979.

Most read articles by the same author(s)